Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Enfermedad residual imperceptible")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1120

  • Page / 45

Export

Selection :

  • and

Reply to: What do we mean by sensitivity when we talk about detecting minimal residual disease? by Steinbach et alROSS, D. M; BRANFORD, S; MELO, J. V et al.Leukemia. 2009, Vol 23, Num 4, pp 819-820, issn 0887-6924, 2 p.Article

Enhanced sensitivity of flow cytometry for routine assessment of minimal residual diseaseDOMINGO, Esther; MORENO, Cristina; SANCHEZ-IBARROLA, Alfonso et al.Haematologica (Roma). 2010, Vol 95, Num 4, pp 691-692, issn 0390-6078, 2 p.Article

Minimal Residual Disease Investigation in Haematological MalignanciesFORONI, Letizia; HOFFBRAND, Victor.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, issn 1521-6926, 233 p.Serial Issue

Value of minimal residual disease in patients with early cancer of the tongueULANOVSKI, David; STERN, Yoram; ROIZMAN, Pepy et al.American journal of otolaryngology. 2004, Vol 25, Num 4, pp 240-244, issn 0196-0709, 5 p.Article

Prognostic Impact of Minimal Residual Disease in CBFB-MYH11-Positive Acute Myeloid LeukemiaCORBACIOGLU, Andrea; SCHOLL, Claudia; NACHBAUR, David et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3724-3729, issn 0732-183X, 6 p.Article

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemiaMORTUZA, Forida Y; PAPAIOANNOU, Mary; MOREIRA, Ilidia M et al.Journal of clinical oncology. 2002, Vol 20, Num 4, pp 1094-1104, issn 0732-183XArticle

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaBUCCISANO, Francesco; MAURILLO, Luca; DEL PRINCIPE, Maria Ilaria et al.Blood. 2012, Vol 119, Num 2, pp 332-341, issn 0006-4971, 10 p.Article

Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From the Children's Oncology GroupCOUSTAN-SMITH, Elaine; SANDLUND, John T; PERKINS, Sherrie L et al.Journal of clinical oncology. 2009, Vol 27, Num 21, pp 3533-3539, issn 0732-183X, 7 p.Article

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetØSTERGAARD, M; NYVOLD, C. G; SCHNITTGER, S et al.Leukemia. 2011, Vol 25, Num 7, pp 1168-1173, issn 0887-6924, 6 p.Article

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignanciesDIEZ-CAMPELO, Maria; PEREZ-SIMON, José Antonio; PEREZ, Jose et al.American journal of hematology. 2009, Vol 84, Num 3, pp 149-152, issn 0361-8609, 4 p.Article

Development of Minimal Residual Disease-Directed Therapy in Acute Myeloid LeukemiaFREEMAN, Sylvie D; JOVANOVIC, Jelena V; GRIMWADE, David et al.Seminars in oncology. 2008, Vol 35, Num 4, pp 388-400, issn 0093-7754, 13 p.Article

PRAME mRNA levels in cases with acute leukemia : Clinical importance and future prospectsPAYDAS, Semra; TANRIVERDI, Kahraman; YAVUZ, Sinan et al.American journal of hematology. 2005, Vol 79, Num 4, pp 257-261, issn 0361-8609, 5 p.Article

Infection VIH et antirétroviraux: succès ou maladie résiduelle ?WINTENBERGER, C; GIRARD, P.-M; CAPEAU, J et al.Médecine et maladies infectieuses. 2012, Vol 42, pp 5-11, issn 0399-077X, 7 p., HS3Article

A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgeryWARD, S. T; JONES, B. G; JEWKES, A. J et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 12, pp 1675-1680, issn 1368-5031, 6 p.Article

Beyond detectable minimal residual disease in chronic lymphocytic leukemiaHILLMEN, Peter.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S23-S28, SUP5Article

Clearing minimal residual disease with rituximab consolidation therapyBRUGGER, Wolfram.Seminars in oncology. 2004, Vol 31, pp 33-37, issn 0093-7754, 5 p., SUP2Article

Monitoring of minimal residual disease in chronic myeloid leukemiaFADERL, Stefan; HOCHHAUS, Andreas; HUGHES, Timothy et al.Hematology/oncology clinics of North America. 2004, Vol 18, Num 3, pp ix-x, issn 0889-8588, 16 p.Article

Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severityBARROWMAN, Jemima; WILEY, Patricia A; HUDON-MILLER, Sarah E et al.Human molecular genetics (Print). 2012, Vol 21, Num 18, pp 4084-4093, issn 0964-6906, 10 p.Article

Minimal Residual Disease in Acute Lymphoblastic LeukemiaCAMPANA, Dario.Seminars in hematology. 2009, Vol 46, Num 1, pp 100-106, issn 0037-1963, 7 p.Article

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemiaARCHAMBEAULT, Sophie; FLORES, Nikki J; ZECCA, Marco et al.Blood. 2008, Vol 111, Num 3, pp 1124-1127, issn 0006-4971, 4 p.Article

Minimal Residual Disease―Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 StudyENG JUH YEOH, Allen; ARIFFIN, Hany; LEE AI CHONG et al.Journal of clinical oncology. 2012, Vol 30, Num 19, pp 2384-2392, issn 0732-183X, 9 p.Article

Wilms' Tumor 1 (WT1) et leucémies aiguës = Wilms' Tumor 1 (WT1) and acute leukemiaRENNEVILLE, Aline; PREUDHOMME, Claude.Hématologie (Montrouge). 2011, Vol 17, Num 1, pp 40-60, issn 1264-7527, 21 p.Article

CD 11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemiaRHEIN, Peter; MITLOHNER, Rita; KARAWAJEW, Leonid et al.Blood. 2010, Vol 115, Num 18, pp 3763-3771, issn 0006-4971, 9 p.Article

Changing paradigms in the treatment of chronic lymphocytic leukemiaFOON, K. A; HALLEK, M. J.Leukemia. 2010, Vol 24, Num 3, pp 500-511, issn 0887-6924, 12 p.Article

How I monitor residual disease in chronic myeloid leukemiaRADICAL, Jerald P.Blood. 2009, Vol 114, Num 16, pp 3376-3381, issn 0006-4971, 6 p.Article

  • Page / 45